• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌筛查中粪便免疫化学试验阳性患者行结肠镜随访的障碍。

Barriers to Follow-up Colonoscopies for Patients With Positive Results From Fecal Immunochemical Tests During Colorectal Cancer Screening.

机构信息

Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California; The University of California Los Angeles Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, University of California David Geffen School of Medicine, Los Angeles, California; Veterans Affairs Health Services Research and Development Center for the Study of Healthcare Innovation, Implementation and Policy, Los Angeles, California.

Veterans Affairs Health Services Research and Development Center for the Study of Healthcare Innovation, Implementation and Policy, Los Angeles, California; Department of Health Policy and Management, Fielding School of Public Health, Los Angeles, California.

出版信息

Clin Gastroenterol Hepatol. 2019 Feb;17(3):469-476. doi: 10.1016/j.cgh.2018.05.022. Epub 2018 May 29.

DOI:10.1016/j.cgh.2018.05.022
PMID:29857147
Abstract

BACKGROUND & AIMS: Colorectal cancer is common yet largely preventable. The fecal immunochemical test (FIT) is a highly recommended screening method, but patients with positive results must receive a follow-up colonoscopy to determine if they have precancerous or cancerous lesions. We characterized colonoscopic follow-up evaluations and reasons for lack of follow-up in a Veterans Affairs (VA) cohort.

METHODS

We conducted a retrospective cross-sectional analysis of patients 50 to 75 years old with a positive FIT result from January 1, 2014, through May 31, 2016, in a network of 12 VAs sites in southern California. We determined the proportion of patients who received a follow-up colonoscopy, median time to colonoscopy, and colonoscopy findings. For patients who did not undergo colonoscopy, we determined the documented reason for lack of colonoscopy and factors associated with declining the colonoscopy examination.

RESULTS

Of the 10,635 FITs performed, 916 (8.6%) produced positive results; 569 of these (62.1%) were followed by colonoscopy. The median time to colonoscopy after a positive FIT result was 83 days (interquartile range, 54-145 d), which did not vary between veterans who received a colonoscopy at a VA facility (81 d; interquartile range, 52-143 d) vs a non-VA site (87 d; interquartile range, 60-154 d) (P = .2). For the 347 veterans (37.9%) who did not undergo follow-up colonoscopy, the reasons were patient-related (49.3%), provider-related (16.4%), system-related (12.1%), or multifactorial (22.2%). Overall, patient decline of colonoscopy (35.2%) was the most common reason.

CONCLUSIONS

In a cohort of veterans with positive results from FITs during CRC screening, reasons for lack of follow-up colonoscopy varied and included patient, provider, and system factors. These findings can be used to reduce barriers to follow-up colonoscopy and to address system-level challenges in scheduling and attrition for colonoscopy.

摘要

背景与目的

结直肠癌较为常见,但大部分是可以预防的。粪便免疫化学检测(FIT)是一种高度推荐的筛查方法,但结果阳性的患者必须接受后续结肠镜检查,以确定是否存在癌前病变或癌症病变。我们对退伍军人事务部(VA)队列中的结肠镜随访评估和缺乏随访的原因进行了描述。

方法

我们对 2014 年 1 月 1 日至 2016 年 5 月 31 日期间在加利福尼亚州南部的 12 个 VA 站点网络中,年龄在 50 至 75 岁之间、FIT 检测结果阳性的患者进行了回顾性横断面分析。我们确定了接受结肠镜随访的患者比例、结肠镜检查的中位时间和结肠镜检查结果。对于未接受结肠镜检查的患者,我们确定了未行结肠镜检查的记录原因以及与拒绝结肠镜检查相关的因素。

结果

在进行的 10635 次 FIT 检测中,有 916 次(8.6%)结果阳性;其中 569 次(62.1%)随后进行了结肠镜检查。阳性 FIT 结果后进行结肠镜检查的中位时间为 83 天(四分位距,54-145 天),在接受 VA 机构结肠镜检查的退伍军人(81 天;四分位距,52-143 天)与非 VA 机构(87 天;四分位距,60-154 天)之间没有差异(P=0.2)。对于 347 名(37.9%)未接受后续结肠镜检查的退伍军人,未行结肠镜检查的原因包括患者相关(49.3%)、提供者相关(16.4%)、系统相关(12.1%)或多因素相关(22.2%)。总体而言,患者拒绝结肠镜检查(35.2%)是最常见的原因。

结论

在 CRC 筛查期间接受 FIT 阳性结果的退伍军人队列中,缺乏结肠镜随访的原因各不相同,包括患者、提供者和系统因素。这些发现可用于减少结肠镜随访的障碍,并解决结肠镜检查中的预约和流失等系统层面的挑战。

相似文献

1
Barriers to Follow-up Colonoscopies for Patients With Positive Results From Fecal Immunochemical Tests During Colorectal Cancer Screening.结直肠癌筛查中粪便免疫化学试验阳性患者行结肠镜随访的障碍。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):469-476. doi: 10.1016/j.cgh.2018.05.022. Epub 2018 May 29.
2
Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.在大型医疗机构中,用粪便免疫化学检测替代愈创木脂粪便潜血试验可增加筛查人数的比例。
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1265-1270.e1. doi: 10.1016/j.cgh.2017.01.025. Epub 2017 Feb 4.
3
Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.在一个安全网医疗系统中,粪便免疫化学检测结果呈阳性后未进行诊断性结肠镜检查的原因。
Am J Med. 2017 Jan;130(1):93.e1-93.e7. doi: 10.1016/j.amjmed.2016.07.028. Epub 2016 Aug 31.
4
Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.粪便免疫化学检测阳性后的患者导航可增加诊断性结肠镜检查,并凸显出随访的多层次障碍。
Dig Dis Sci. 2021 Nov;66(11):3760-3768. doi: 10.1007/s10620-021-06866-x. Epub 2021 Feb 20.
5
Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.粪便结直肠癌筛查试验结果呈阳性后,结肠镜检查时间延长的后果。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1445-1451.e8. doi: 10.1016/j.cgh.2016.05.017. Epub 2016 May 19.
6
Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.患者、医生及环境因素对结直肠癌筛查异常结果结肠镜随访中人口统计学及健康差异的影响。
Cancer. 2017 Sep 15;123(18):3502-3512. doi: 10.1002/cncr.30765. Epub 2017 May 11.
7
Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.无症状粪便免疫化学检测阳性患者的腺瘤检出率。
Dig Dis Sci. 2018 May;63(5):1167-1172. doi: 10.1007/s10620-018-4984-9. Epub 2018 Feb 22.
8
Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.结直肠癌混合筛查策略的健康获益和成本效益。
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.
9
Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.OC-Light 便潜血免疫化学法检测阳性后的结肠镜检查的检出率。
Clin Gastroenterol Hepatol. 2018 Oct;16(10):1593-1597.e1. doi: 10.1016/j.cgh.2018.04.014. Epub 2018 Apr 13.
10
Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.在加利福尼亚南部 8 家联邦合格健康中心,基于粪便免疫化学检测异常的诊断性结肠镜检查完成情况和检测质量:改善筛查结果的机会。
Cancer. 2019 Dec 1;125(23):4203-4209. doi: 10.1002/cncr.32440. Epub 2019 Sep 3.

引用本文的文献

1
Patient preferences and perceived barriers to follow-up care in a pharmacy-based colorectal cancer screening program: a national survey.基于药房的结直肠癌筛查项目中患者的偏好及后续护理的感知障碍:一项全国性调查。
Cancer Causes Control. 2025 Aug 15. doi: 10.1007/s10552-025-02045-9.
2
Adherence to Follow-Up Colonoscopy After a Positive Stool-Based Test in Patients Aged 45-49 Years: Real-World Differences Between Multitarget Stool DNA Testing and Fecal Immunochemical or Fecal Occult Blood Testing.45-49岁粪便检测呈阳性患者后续结肠镜检查的依从性:多靶点粪便DNA检测与粪便免疫化学或粪便潜血检测在现实世界中的差异
Gastro Hep Adv. 2025 May 16;4(9):100706. doi: 10.1016/j.gastha.2025.100706. eCollection 2025.
3
Health Policy and Screening for Colorectal Cancer in the United States.
美国的卫生政策与结直肠癌筛查
Cancers (Basel). 2025 Jun 16;17(12):2003. doi: 10.3390/cancers17122003.
4
Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer.一种基于循环肿瘤DNA的血液检测用于筛查结直肠癌的临床验证
JAMA. 2025 Jun 2. doi: 10.1001/jama.2025.7515.
5
Optimal Approach to Colorectal Cancer Screening.结直肠癌筛查的最佳方法。
Gastroenterol Hepatol (N Y). 2025 Mar;21(3):163-171.
6
Legal-involved veterans are less likely to receive guideline-concordant colorectal cancer screening.涉及法律问题的退伍军人接受符合指南的结直肠癌筛查的可能性较小。
BMC Health Serv Res. 2025 Mar 4;25(1):333. doi: 10.1186/s12913-025-12490-6.
7
Patients' experiences with 'sludge' (administrative burden) in the cancer screening process and its relationship with screening completion, experience and health system distrust.患者在癌症筛查过程中对“ sludge ”(行政负担)的体验及其与筛查完成情况、体验和对卫生系统不信任的关系。
Fam Med Community Health. 2024 Sep 18;12(Suppl 2):e002933. doi: 10.1136/fmch-2024-002933.
8
Lack of Adherence to Guidelines on Follow-Up Colonoscopy after an Abnormal Stool Occult Blood Test.粪便潜血试验异常后未遵循结肠镜检查随访指南的情况。
J Gastrointest Cancer. 2024 Sep;55(3):1456-1459. doi: 10.1007/s12029-024-01039-1. Epub 2024 May 20.
9
Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.在中国高危人群中,将结肠镜检查推迟 6 个月会增加结直肠癌的检出率。
Cancer Med. 2023 May;12(10):11816-11827. doi: 10.1002/cam4.5850. Epub 2023 Mar 23.
10
Using cognitive interviews to improve a measure of organizational readiness for implementation.使用认知访谈来改进实施准备度的衡量。
BMC Health Serv Res. 2023 Jan 27;23(1):93. doi: 10.1186/s12913-022-09005-y.